Want to see HK:2575 full AI Analyst Report?
Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Revenue
2 Followers
Xuanzhu Biopharmaceutical Co., Ltd. Class H Revenue
Xuanzhu Biopharmaceutical Co., Ltd. Class H had a revenue of 40.10M in the quarter ending Jun 30, 2026, with 1.61%. This bring the company's revenue in the last twelve months to 116.94M, Increased 34.97%. In the fiscal year ending Dec 31, 2025, Xuanzhu Biopharmaceutical Co., Ltd. Class H had annual revenue of 56.15M with 72.08% growth.
- Revenue (ttm)
- 116.94M
- Revenue Growth
- 237.19%
- P/S Ratio
- 71.31
- Revenue/Employee
- HKD 163,221
- Employees
- 344
- Market Cap
- HKD 4.00B
Revenue Chart
Xuanzhu Biopharmaceutical Co., Ltd. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.15M | 23.52M | 72.08% |
| Dec 31, 2024 | 32.63M | 32.60M | 101724.47% |
| Dec 31, 2023 | 32.04K | 32.04K | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.